ResMed Inc (RMD)

237.27 +5.69 (+2.46%) USD  |  NYSE  |  Dec 20, 16:00
237.62 +0.35 (+0.15%) After-Hours: 20:00
More

ResMed Max Drawdown (5Y): 53.98% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Boston Scientific Corp 43.49%
Haemonetics Corp 68.62%
Globus Medical Inc 47.91%
Zimmer Biomet Holdings Inc 49.73%
Merit Medical Systems Inc 60.66%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 0.1306
Beta (5Y) 0.6841
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 33.07%
Historical Sharpe Ratio (5Y) 0.2802
Historical Sortino (5Y) 0.452
Monthly Value at Risk (VaR) 5% (5Y Lookback) 14.09%